Resources

Regulatory and Scale-up Support: With You Every Step of the Journey!
June 19th, 2025VideoCell & Gene Therapies, Vaccines
Purpose-built VSEs for VPC 2.0 and FectoVIR® Combination Platforms
June 19th, 2025VideoCell & Gene Therapies
Maximize Viral Yields with Virica’s Curated VSE™ Library
June 19th, 2025VideoCell & Gene Therapies, Vaccines
The Virica Advantage: Rapidly Maximize Viral Yields and Cut Production Costs
June 19th, 2025VideoCell & Gene Therapies, Vaccines
Rapidly Optimizing Viral Vector Production Without Process Disruption
June 19th, 2025VideoCell & Gene Therapies, Vaccines
Small Molecule Antagonists of Cellular Innate Immunity for Enhanced Cell and Gene Therapy Manufacturing
June 14th, 2025PosterCell & Gene Therapies
Optimizing AAV Production: Accelerating Discovery of Small Molecule Enhancers using High Throughput Virology and Design of Experiments
May 10th, 2025PosterCell & Gene Therapies
Increasing Lentivirus Production and T-cell Transduction Efficiency: Discovery and Validation of Next Generation Viral Sensitizer (VSE™) Compounds
May 10th, 2025PosterCell & Gene Therapies
Increasing AAV8 Yields in the iCELLis™ Nano Bioreactor Using VSE™ Technology
April 29th, 2025WhitepaperCell & Gene Therapies
High-Throughput Screening of Next Generation Small Molecule Enhancers and Process Automation in Cloud-Connected Bioreactors
April 20th, 2025PosterCell & Gene Therapies

Virica uses cookies to provide a better website experience of our website. I agree to the Privacy Policy and Terms of Use. OK